Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2004 Feb 6;174(1):35–42. doi: 10.1016/0042-6822(90)90051-R

Superinfection exclusion of vaccinia virus in virus-infected cell cultures

Linda Christen 1, Janny Seto 1, Edward G Niles 1,1
PMCID: PMC7130625  PMID: 2294646

Abstract

Vaccinia virus-infected BSC 40 cells do not permit the replication of superinfecting vaccinia virus. The extent of superinfecting virus propagation depends on the time of superinfection; there is 90% exclusion by 4 hr after the initial infection, and more than 99% by 6 hr. When superinfection is attempted at 6 hr after infection, the superinfecting virus is incapable of carrying out DNA replication or early gene transcription, demonstrating that an early event in the virus life cycle is inhibited. The rate of adsorption of the superinfecting virus is unaltered which shows that exclusion is affected at a point between adsorption and early gene transcription. In order to exclude superinfection, the primary infecting virus does not require replication of its DNA or expression of its late genes but it must express one or more early genes.

References

  1. Bablanian R., Coppola G., Scribani S., Esteban M. Inhibition of protein synthesis by vaccinia virus. III. The effect of ultraviolet-irradiated virus on the inhibition of protein synthesis. Virology. 1981;112:1–12. doi: 10.1016/0042-6822(81)90606-1. [DOI] [PubMed] [Google Scholar]
  2. Chakrabarti S., Brechling K., Moss B. Vaccinia virus expression vector: Coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 1985;5:3403–3409. doi: 10.1128/mcb.5.12.3403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Condit R.C., Motyczka A. Isolation and preliminary characterization of temperature-sensitive mutants of vaccinia virus. Virology. 1981;113:224–241. doi: 10.1016/0042-6822(81)90150-1. [DOI] [PubMed] [Google Scholar]
  4. Condit R.C., Motyczka A., Spizz G. Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus. Virology. 1983;128:429–443. doi: 10.1016/0042-6822(83)90268-4. [DOI] [PubMed] [Google Scholar]
  5. Ensinger M.J. Isolation and genetic characterization of temperature-sensitive mutants of vaccinia virus WR. J. Virol. 1982;43:778–790. doi: 10.1128/jvi.43.3.778-790.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ensinger M.J., Rovinsky M. Marker rescue of temperature-sensitive mutations of vaccinia virus WR: Correlation of genetic and physical maps. J. Virol. 1983;48:419–428. doi: 10.1128/jvi.48.2.419-428.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Esposito J., Condit R., Obijeski J. The preparation of orthopoxvirus DNA. J. Virol. Methods. 1981;2:175–179. doi: 10.1016/0166-0934(81)90036-7. [DOI] [PubMed] [Google Scholar]
  8. Evans E., Traktman P. Molecular genetic analysis of a vaccinia virus gene with an essential role in DNA replication. J. Virol. 1987;61:3152–3162. doi: 10.1128/jvi.61.10.3152-3162.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Johnson R.M., Spear P.G. Herpes simplex virus glycoprotein D mediates interference with herpes simplex virus infection. J. Virol. 1989;63:819–827. doi: 10.1128/jvi.63.2.819-827.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Joklik W.K. The purification of four strains of poxvirus. Virology. 1962;18:9–18. doi: 10.1016/0042-6822(62)90172-1. [DOI] [PubMed] [Google Scholar]
  11. Joklik W.K. The intracellular uncoating of poxvirus DNA. I. The fate of radioactively-labeled rabbitpox virus. J. Mol. Biol. 1964;8:263–276. doi: 10.1016/s0022-2836(64)80136-4. [DOI] [PubMed] [Google Scholar]
  12. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 1970;227:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  13. Moss B. Inhibition of HeLa cell protein synthesis by the vaccinia virion. J. Virol. 1968;2:1028–1037. doi: 10.1128/jvi.2.10.1028-1037.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Moss B., Rosenblum E.N., Grimley P.M. Assembly of virus particles during mixed infection with wild-type vaccinia and a rifampicin-resistant mutant. Virology. 1971;45:135–148. doi: 10.1016/0042-6822(71)90120-6. [DOI] [PubMed] [Google Scholar]
  15. Moss B., Salzman M.P. Sequential protein synthesis following vaccinia virus infection. J. Virol. 1968;2:1016–1027. doi: 10.1128/jvi.2.10.1016-1027.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Niles E.G., Condit R.C., Caro P., Davidson K., Matusick L., Seto J. Nucleotide sequence and genetic map of the 16-kb vaccinia virus HindIII D fragment. Virology. 1986;153:96–112. doi: 10.1016/0042-6822(86)90011-5. [DOI] [PubMed] [Google Scholar]
  17. Niles E.G., Lee-Chen G.J., Shuman S., Moss B., Broyles S.S. Vaccinia virus gene D12L encodes the small subunit of the viral mRNA capping enzyme. Virology. 1989 doi: 10.1016/0042-6822(89)90194-3. in press. [DOI] [PubMed] [Google Scholar]
  18. Niles E.G., Seto J. Vaccinia virus gene D8 encodes a virion transmembrane protein. J. Virol. 1988;62:3772–3778. doi: 10.1128/jvi.62.10.3772-3778.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Oda K., Joklik W.K. Hybridization and sedimentation studies on “early” and “late” vaccinia messenger RNA. J. Mol. Biol. 1967;27:395–419. doi: 10.1016/0022-2836(67)90047-2. [DOI] [PubMed] [Google Scholar]
  20. Pacha R.F., Condit R.C. Characterization of a temperature-sensitive mutant of vaccinia virus reveals a novel function that prevents virus-induced breakdown of RNA. J. Virol. 1985;56:395–403. doi: 10.1128/jvi.56.2.395-403.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Palese P., Tobita K., Ueda M. Characterization of temperature sensitive influenza mutants defective in neuraminidase. Virology. 1974;61:397–410. doi: 10.1016/0042-6822(74)90276-1. [DOI] [PubMed] [Google Scholar]
  22. Roseman N.A., Hruby D.E. Nucleotide sequence and transcript organization of a region of the vaccinia virus genome which encodes a constitutively expressed gene required for DNA replication. J. Virol. 1987;61:1398–1406. doi: 10.1128/jvi.61.5.1398-1406.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Salzman M.P., Sebring E.D. Sequential formation of vaccinia virus proteins and viral deoxyribonucleic acid. J. Virol. 1967;1:9–23. doi: 10.1128/jvi.1.1.16-23.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Seto J., Celenza L.M., Condit R.C., Niles E.G. Genetic map of the vaccinia virus Hindlll D fragment. Virology. 1987;160:110–119. doi: 10.1016/0042-6822(87)90051-1. [DOI] [PubMed] [Google Scholar]
  25. Southern E. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 1975;98:503–517. doi: 10.1016/s0022-2836(75)80083-0. [DOI] [PubMed] [Google Scholar]
  26. Thomas P. Hybridization of denatured RNA transferred or dotted to nitrocellulose paper. In: Wu R., Grossman L., Moldave K., editors. Vol. 100. Academic Press; New York: 1983. pp. 255–266. (Methods in Enzymology). [DOI] [PubMed] [Google Scholar]
  27. Vlasak R., Luytjes W., Leider J.P., Spaan W., Palese P. The E3 protein of coronavirus is a receptor-destroying enzyme with acetylestrase activity. J. Virol. 1989;62:4686–4690. doi: 10.1128/jvi.62.12.4686-4690.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Virology are provided here courtesy of Elsevier

RESOURCES